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Long Stents are Likely to be Under-expanded with Stent Delivery Balloon, Post-
stent Optimal Coherence Tomography Assessment
Hiroyuki Shibata1, Yoichi Kijima1, Tomoya Masano1, Ryoji Nagoshi1,
Amane Kozuki1, Kimitake Imamura1, Yoshiro Tsukiyama1, Kenichi Yanaka1,
Shinsuke Nakano1, Junya Shite1
1Osaka Saiseikai Nakatsu Hospital, Osaka, Japan
Background: The 2nd generation DES improved the clinical outcome, however, stent
underexpansion and malapposition should be avoided to prevent stent restenosis and
subacute stent thrombosis (DES failure). Previous study showed that stent length was
strongly associated with DES failure.
Methods: We investigated 172 de novo coronary lesions without calciﬁcation treated
with single 2nd generation DES (Xience Prime, Promus Element, Nobori, and
Resolute Integrity) under optical coherence tomography (OCT) guidance. After
deployment of DES with stent delivery balloon by 2 or 3 times inﬂations, minimum
stent area (MSA) and distance between the strut and vessel wall of malapposed struts
were analyzed by OCT. We also calculated a ratio of measured MSA to estimated
stent area (M/E ratio) obtained by compliance chart in each DES. Long stent was
deﬁned that stent length was 28-38mm and short stent was less than 28mm. We
compared long stent group (N¼46) with short stent group (N¼126).
Results: Baseline and lesion characteristics were similar between two groups.
However, M/E ratio of MSA in long stent group was signiﬁcantly smaller than that in
short stent group (0.59 vs. 0.66 p¼0.001). The distance between the strut and vessel
wall of malapposed struts in long stent group was larger than that in short stent group
(0.319 vs. 0.245mm, p¼0.015).
Conclusions: Long stent did not achieve optimal stent expansion with delivery
balloon even in non-calciﬁed lesion. After stent deployment, we should perform
OCT to evaluate stent under expansion and stent malapposition, and assess
whether another post dilatation balloon is needed or not, especially in long
stenting.Long stent
(28mm)
N=46
Short stent
(<28mm)
N=126 p value
Age 66.4 68.5 0.289
Male, % 72.7 71.3 0.860
Diabetes Mellitus, % 56.5 43.6 0.136
Hypertension, % 78.3 73.8 0.553
Dyslipidemia, % 65.2 57.9 0.391
Stent size, mm 2.70 2.82 0.095
Stent Inﬂation
pressure, atm
10.7 11.5 0.038
Minimum stent
area, mm2
3.66 4.58 0.002
Maximum stent
area, mm2
6.16 6.66 0.174
Estimated stent
area,mm2
6.18 6.86 0.056
Ratio of measured
/ Estimated stent
area
0.59 0.66 0.001
Ratio of minimum
/ maximum stent
area
0.63 0.73 <0.0001
Distance of stent
malapposition, mm
0.319 0.245 0.015
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Comparative incidence of optical coherence tomography features indicative of
uncorrected stent deployment in patients with and without major adverse cardiac
events in the OCT guided arm of the CLI-OPCI study
Laura Gatto1, Alberto Chisari2, Alessio La Manna3, Francesco Burzotta4,
Luca Di Vito1, Maria Teresa Mallus5, Alberto Cremonesi6, Alessandro Pappalardo5,
Mario Albertucci5, Francesco Prati7
1San Giovanni Addolorata Hospital, Roma, Italy, 2University of Catania, Cardiology,
Italy, 3Ferrarotto Hospital, Catania, Catania, Italy, 4Catholic University Hospital of
the Sacred Heart, Roma, Italy, 5s. giovanni hospital, rome, Italy, 6N/A, Cotignola,
Italy, 7San Giovanni Hospital, Rome, Italy
Background: The Centro per la Lotta contro l'Infarto-Optimisation of Percutaneous
Coronary Intervention study suggested that the use of optical coherence tomography
(OCT) can improve the clinical outcome in patients undergoing PCI. The aim of this
study was to compare the incidence of the OCT-features predicting adverse events in
patients who suffered from cardiac death or myocardial infarction (MACE group)
respect to patients who had no MACE (Control group).
Methods: 22 patients out of 335 had a MACE at 1 year of follow-up (MACE group)
vs the remaining 313 without complications (Control group). Stents were assessed by
OCT to address the features indicative of non-optimal stent deployment such as stent
under-expansion, malapposition, edge dissection, thrombus burden and reference
lumen narrowing. OCT images were analysed applying the quantitative thresholds of
the CLI-OPCI study.
Results: The OCT features indicative of non-optimal stent deployment were observed
more frequently in the MACE group compared to the Control group (ﬁgure 1).
Excluding malapposition, that did not differ in the 2 groups, the percentage of cases
which had at least one of the OCT missed criteria was signiﬁcantly higher in the
MACE group (89% vs 39%, P<0.001).P
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SConclusions: Patients with MACE in the CLI-OPCI study despite the use of OCT
guided strategy were found to have more often an uncorrected stent deployment based
on the OCT criteria. These results further emphasizes the role of OCT in optimizing
stent implantation.
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Differences in neointimal coverage among bare-metal stent, zotarolimus-eluting
stent, everolimus-eluting stent and biolimus–eluting stent at 9 months after
implantation using optical coherence tomography in patients with ST-segment
elevation myocardial infarction
Koichiro Sonoda1, Shiro Hata1, Satoshi Ikeda2, Seiji Koga2, Koji Maemura2
1Sasebo City General Hospital, Sasebo, Japan, 2Nagasaki University Graduate
School of Biomedical Sciences, Nagasaki, Japan
Background: Percutaneous coronary intervention with drug-eluting stents for patients
with ST-segment elevation myocardial infarction (STEMI) reduces target lesion
revascularization, but drug-eluting stents have an increased risk of very late stent
thrombosis. Endothelial coverage of stents is a key factor in stent thrombosis. This
study examined neointimal coverage of bare-metal stent (BMS), and 3 types of
second-generation drug-eluting stents [zotarolimus-eluting stent (E-ZES), everolimus-
eluting stent (EES) and biolimus-eluting stent (BES)] in STEMI patients using optical
coherence tomography (OCT).
Methods: Eighty-eight STEMI patients underwent follow-up coronary angiography
and OCT at 9 months after stent implantation (BMS, n¼22; E-ZES, n¼21; EES,
n¼22; BES, n¼23). Using OCT, we measured thickness inside every strut and area
between struts and vessel wall, and evaluated neointimal coverage and malapposition
of stents. The relationship of strut condition to remodeling index before Percutaneous
coronary intervention by intravascular ultrasound was also examined.
Results: As shown in the table 1, restenosis rate, neointimal coverage thickness and
area rate were signiﬁcantly lower with EES and BES than with BMS and E-ZES,
while the malapposed rate was signiﬁcantly higher in EES and BES. Uncovered struts
were most frequently observed in EES. In addition, evagination/strut rate was highestacts/POSTER/Intravascular Imaging and PCI B167
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Sin BES among the various stents, showing a signiﬁcant correlation with positive
remodeling by intravascular ultrasound (r¼0.42, p¼0.047).
Conclusions: Differences in neointimal coverage as assessed by OCT in BMS, E-
ZES, EES and BES were found after 9-month implantation in STEMI patients. This
might cause differences in the development of stent thrombosis. Furthermore, E-ZES
might have potential to lead to early discontinuation of dual antiplatelet therapy
among these second-generation drug-eluting stents.Table 1: Differences related to QCA and OCT ﬁndings after 9-months implan-
tationamong BMS, E-ZES, EES and BES
BMS E-ZES EES BES
Restenosis rate :
QCA (%)
38.2 27.1 14.9yy,¤ 14.8xx,<
Target lesion
revascularization
rate (%)
13.6 4.8 0 0
Covered strut rate
(%)
98.4 99.0 93.7yy,¤¤ 96.4
Uncovered strut
rate (%)
0.17 0.18 3.58yy,¤¤ 0.99<
Malapposed rate
(%)
0.82 0 1.73¤¤ 1.77<<
Malapposed
covered rate
(%)
0.46 0 1.1¤ 1.73<<
Malapposed
uncovered rate
(%)
0.36 0 0.63y,¤¤ 0.05z
Tissue coverage
thickness (mm)
346.8 267.0 93.4yy,¤¤ 73.4xx,<<
Neointimal
coverage area
rate (%)
35.3 28.5 11.5yy,¤¤ 9.16xx,<<
Evagination/strut
rate (%)
0.8 0.02 2.45¤ 8.12xx,z,<<
yp<0.05 (BMS vs. EES); yy p<0.01 (BMS vs. EES); xx p<0.01 (BMS vs. BES); ¤ p<0.05 (E-ZES
vs. EES),¤¤ p<0.01 (E-ZES vs. EES); < p<0.05 (E-ZES vs. BES); << p<0.01 (E-ZES vs. BES); z
p<0.05 (EES vs. BES).TCT-557
IVUS Echogenicity Analysis of the Paclitaxel-Eluting Absorbable Magnesium
Scaffold (DREAMS)
Michael Haude1, Nico Bruining2, Raimund Erbel3, Paul Erne4, Stefan Verheye5,
Paul Vermeersch5, Hubertus Degen1, Dirk Boese3, Ron Waksman6, Jacques Koolen7
1Städtische Kliniken Neuss, Lukaskrankenhaus GmbH, Neuss, Germany,
2Thoraxcenter, Erasmus Medical Center, Rotterdam, Netherlands, 3West German
Heart Center, Essen, Germany, 4Luzerner Kantonsspital, Luzern, Switzerland, 5ZNA
Middelheim, Antwerp, Belgium, 6MedStar Health Research Institute, Washington,
DC, 7Catharina Ziekenhuis, Eindhoven, Netherlands
Background: The aim of this study is to explore the application of IVUS derived
parameters to act as a surrogate monitoring the absorption and degradation
process of a Paclitaxel-Eluting-Absorbable Magnesium Scaffold (DREAMS)
implanted in human coronary arteries. The ultrasonic changes of this scaffold are
assumed to have a strong relationship towards its degradation and bioresorption
process.
Methods: Serial IVUS data of the BIOSOLVE-I study was analysed by applying
differential echogenicity analyses, a method which previously showed that visual
changes of the ultrasonic appearance of bioresorbable scaffolds can be quantitatively
identiﬁed.
Results: In post-implantation IVUS images, the struts of the magnesium scaffold
appear as clearly visible and quantiﬁable hyperechogenic spots without, unlike
calciﬁed areas, causing any acoustic shadowing. Echogenicity analyses of pre- and
post-implantation scaffolded segments showed a signiﬁcant increase of %hyper-
echogenicity caused by the scaffold from 9 to 22% (p<0.001); respectively (Figure 1).
At 6 months the %hyperechogenicity decreased signiﬁcantly from 22 to 16%
(p<0.001). At further time points the scaffolded segments showed still a continuous
further decrease of %hyperechogenicity, however, leveling off to a non-signiﬁcant
change between 12 and 18 months, 13 vs. 12% (p¼0.5).B168 JACC Vol 62/18/Suppl B j October 27–NoveConclusions: The magnesium scaffold shows a continuous decrease of its ultrasonic
appearance over time and the quantitative differential echogenicity evaluation
supports that the DREAMS absorption is likely to be completed at 6-months.
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Adjunctive Rotational Atherectomy Before Drug-Eluting Stent Deployment is
not an Essential Strategy for Severely Calciﬁed Stenosis Identiﬁed by Pre-
procedural Intravascular Ultrasound: Mid-term Angiographic and Clinical
Outcomes.
Satoko Tahara1, Yusuke Fujino1, Hiroto Yabushita1, Kensuke Takagi1,
Michihiko Sato1, Satoru Mitomo1, Hiroyoshi Kawamoto1, Takahiro Matsumoto1,
Takayuki Warisawa1, Yusuke Watanabe1, Hisaaki Ishiguro1, Keiko Fukino1,
Naoyuki Kurita1, Koji Hozawa1, Shotaro Nakamura1, Sunao Nakamura1
1New Tokyo Hospital, Matsudo, Japan
Background: Rotational atherectomy (RA) is an effective strategy for the modiﬁ-
cation of heavily calciﬁed coronary lesions, particularly those which balloon catheters
or imaging devices cannot cross. Identiﬁcation of extended superﬁcial calcium by
intravascular ultrasound (IVUS) has led to selected vessel modiﬁcation with RA to
facilitate stent delivery and expansion. We assessed the necessity of lesion prepara-
tion with RA for heavily calciﬁed stenoses identiﬁed by pre-procedural IVUS in
drug-eluting stent (DES) era.
Methods: From January 2010 through October 2012, 143 de novo severely calciﬁed
stenoses (deﬁned as calcium arc of >270 degrees as identiﬁed by pre-procedural
IVUS) in 143 patients were assigned to RA followed by stenting or stenting without
RA at the discretion of the operator. Angiographically documented calciﬁed lesions
that an IVUS catheter could not cross were excluded. IVUS morphometric analysis
was performed. Cardiac death, myocardial infarction, stent thrombosis, target lesion
revascularization (TLR) and target vessel revascularization (TVR) were assessed at
mid-term.
Results: RA was performed in 51/143 lesions (35.7%). Complete procedural success
was achieved in all cases. Second-generation DES was used in 121 cases (84.6%).
Patient and lesion characteristics were similar in both populations. Minimal lumen
area at post-procedure was larger in RA patients vs. non-RA patients (6.952.30mm2
vs. 6.061.86mm2, p¼0.02). No cardiac death and stent thrombosis occurred in either
population. There was no difference in myocardial infarction between RA patients and
non-RA patients (7.8% vs. 2.2%, p¼0.11). RA patients showed a trend of higher TLR
and TVR vs. non-RA patients (TLR: 19.6% vs. 9.8%, p¼0.097, TVR: 21.6% vs.
9.8%, p¼0.052). Multivariable logistic regression analysis showed chronic kidney
disease on hemodialysis to be the strongest independent predictor of TLR (OR, 5.86,
95% CI 1.93 -17.80, p¼0.002) and TVR (OR, 5.02, 95% CI 1.74-14.47, p¼0.003).
Conclusions: In conclusion, DES implantation without RA could be a default strategy
for severely calciﬁed lesions, even those with ring calciﬁcation, when IVUS assess-
ment is possible at pre-procedure.
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Incidence, Predictors, and Three-Year Outcome of Tissue Prolapse After Stent
Implantation in ST-Segment Elevation Myocardial Infarction Patients
Hyuck-Jun Yoon1, In-Cheol Kim2, Jeong-Eun Lee2, Yun-Kyeong Cho2,
Hyoung-Seob Park2, Hyungseop Kim2, Chang-Wook Nam2, Yoon-Nyun Kim2,
Kwon-Bae Kim2
1Keimyung University Dongsan Medical Center, Daegu, Korea, Republic of,
2Keimyung University Dongsan Medical Center, Daegu, Korea
Background: Several observational studies have shown that tissue prolapse (TP)
lesions detected by intravascular ultrasound after stent implantation in coronary artery
diseases are not fatal phenomena. However data are lacking about their characteristics
and long term outcomes in patients with ST-segment elevation myocardial infarction
(STEMI) undergoing primary percutaneous coronary intervention (PCI).
Methods: From August 1, 2008, to December 31, 2009, one hundred eight patients
who underwent primary PCI with IVUS under diagnosis of STEMI were enrolled in
this study. Fifty four patients (50.0%) showed TP in IVUS after stent implantation.
Clinical characteristics, angiographic and IVUS data were statistically analyzed
according to presence of TP. (TP+ vs. TP-) One month, one year, two years, and three
years clinical follow up was performed.
Results: In TP + group, EF was lower (47.58.0% vs. 52.38.8%, p¼0.004), peak
creatine kinase-myocardial band(CK-MB) level was higher (230.8219.5 mg/dl vs.mber 1, 2013 j TCT Abstracts/POSTER/Intravascular Imaging and PCI
